Literature DB >> 2527034

Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.

M Sakai1, M Watanuki, O Matsuo.   

Abstract

When the extent of plasminogen activation by staphylokinase (SAK) or streptokinase (SK) was measured in human plasma, SAK barely induced plasminogen activation, whereas SK activated plasminogen significantly. When the plasma was clotted with thrombin, the plasminogen activation by SAK was markedly enhanced, but that of SK was little enhanced. Similarly, in a purified system composed of plasminogen, fibrinogen and alpha 2-plasmin inhibitor (alpha 2-PI, alpha 2-antiplasmin), such a fibrin clot increased the activity of SAK significantly. However, when alpha 2-PI was removed from the reaction system, enhancement of the SAK reaction was not observed. In addition, SAK as distinct from SK, showed very little interference with the action of alpha 2-PI. Plasminogen activation by SAK is thus essentially inhibited by alpha 2-PI, but this reaction is not inhibited in fibrin clots. These results suggest that SAK forms a complex with plasminogen, which binds to fibrin and induces fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2527034     DOI: 10.1016/0006-291x(89)92385-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Enhancement of secretion and extracellular stability of staphylokinase in Bacillus subtilis by wprA gene disruption.

Authors:  S J Lee; D M Kim; K H Bae; S M Byun; J H Chung
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

Review 2.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

Review 3.  Novel thrombolytic agents.

Authors:  M Verstraete; H R Lijnen
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

Review 4.  Thrombolytic Enzymes of Microbial Origin: A Review.

Authors:  Deepti Diwan; Zeba Usmani; Minaxi Sharma; James W Nelson; Vijay Kumar Thakur; Graham Christie; Gustavo Molina; Vijai Kumar Gupta
Journal:  Int J Mol Sci       Date:  2021-09-28       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.